A Phase I Study to Determine the Pharmacokinetics of Nestorone Delivered with the Metered Dose Transdermal System (MDTS) in Postmenopausal Women, to be used in contraceptio
Phase 1
Completed
- Conditions
- ContraceptionReproductive Health and Childbirth - Contraception
- Registration Number
- ACTRN12605000523606
- Lead Sponsor
- FemPharm Pty Ltd and/or Acrux DDS Pty Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 6
Inclusion Criteria
Healthy post-menopausal women
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method